Bausch Health Companies (BHC) Total Debt (2009 - 2026)
Bausch Health Companies (BHC) posted Total Debt of $21.6 billion for Q2 2026, little changed sequentially from $21.7 billion in Q1 2026, and down 4.47% YoY from $22.6 billion in Q2 2025.
Bausch Health Companies (BHC) Total Debt (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Total Debt for 18 years, with the latest figure at $21.6 billion in Q2 2026.
- Quarterly Total Debt fell 4.47% year-over-year to $21.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.6 billion (down 4.47% YoY) and the FY2025 annual result came in at $21.0 billion, down 13.37% from the prior year.
- Total Debt steadied at $21.6 billion in Q2 2026 per BHC's latest filing, from $21.7 billion in the prior quarter.
- Over five years, Total Debt peaked at $24.3 billion in Q4 2024 and troughed at $21.0 billion in Q2 2023.
- A 5-year average of $22.1 billion and a median of $21.9 billion in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2023 and 2025: Total Debt increased 7.74% in 2023, then decreased 13.37% in 2025.
- Over 5 years, Total Debt stood at $21.2 billion in 2022, then gained by 7.74% to $22.8 billion in 2023, then rose by 6.36% to $24.3 billion in 2024, then declined by 13.37% to $21.0 billion in 2025, then gained by 2.69% to $21.6 billion in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $21.6 billion, $21.7 billion, and $21.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.86 Bn | 40.20 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 32.13 Bn | 30.45 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - | 760.00 Mn |
| 10 | Bausch Health Companies | 2.56 Bn | 721.37 Mn | 2.10 Bn | 21.61 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.61 Bn |
| Mar 31, 2026 | 21.65 Bn |
| Dec 31, 2025 | 21.04 Bn |
| Sep 30, 2025 | 21.04 Bn |
| Jun 30, 2025 | 22.62 Bn |
| Mar 31, 2025 | 21.79 Bn |
| Dec 31, 2024 | 21.62 Bn |
| Sep 30, 2024 | 21.96 Bn |
| Jun 30, 2024 | 21.66 Bn |
| Mar 31, 2024 | 22.07 Bn |
| Dec 31, 2023 | 22.39 Bn |
| Sep 30, 2023 | 22.97 Bn |
| Jun 30, 2023 | 20.55 Bn |
| Mar 31, 2023 | 21.10 Bn |
| Dec 31, 2022 | 21.20 Bn |
| Sep 30, 2022 | 21.22 Bn |
| Jun 30, 2022 | 21.96 Bn |
| Mar 31, 2022 | 23.17 Bn |
| Dec 31, 2021 | 22.65 Bn |
| Sep 30, 2021 | 22.36 Bn |